Leelyn Smith LLC lifted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 8.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,512 shares of the technology company’s stock after purchasing an additional 584 shares during the quarter. Leelyn Smith LLC’s holdings in Veeva Systems were worth $1,577,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of VEEV. Advisors Asset Management Inc. acquired a new stake in Veeva Systems in the 1st quarter worth approximately $28,000. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of Veeva Systems in the third quarter valued at approximately $26,000. Blue Trust Inc. lifted its stake in shares of Veeva Systems by 3,460.0% in the second quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock worth $33,000 after buying an additional 173 shares during the last quarter. DT Investment Partners LLC bought a new stake in shares of Veeva Systems during the 2nd quarter worth $35,000. Finally, Fairscale Capital LLC bought a new stake in shares of Veeva Systems during the 2nd quarter worth $46,000. Institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Performance
NYSE VEEV opened at $216.59 on Friday. Veeva Systems Inc. has a 52 week low of $165.12 and a 52 week high of $240.68. The stock’s 50 day moving average price is $214.54 and its two-hundred day moving average price is $201.19. The stock has a market capitalization of $35.07 billion, a price-to-earnings ratio of 57.76, a PEG ratio of 2.07 and a beta of 0.81.
Analysts Set New Price Targets
VEEV has been the subject of a number of research analyst reports. Needham & Company LLC reissued a “buy” rating and set a $260.00 target price on shares of Veeva Systems in a research report on Friday, November 8th. Raymond James boosted their price objective on Veeva Systems from $230.00 to $235.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Guggenheim increased their target price on Veeva Systems from $233.00 to $249.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. UBS Group lifted their price target on Veeva Systems from $185.00 to $215.00 and gave the stock a “neutral” rating in a research report on Monday, August 26th. Finally, Robert W. Baird reduced their price objective on Veeva Systems from $251.00 to $245.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and a consensus price target of $236.92.
View Our Latest Stock Report on Veeva Systems
Insider Buying and Selling at Veeva Systems
In other news, insider Thomas D. Schwenger sold 1,126 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $240.01, for a total value of $270,251.26. Following the sale, the insider now directly owns 27,013 shares of the company’s stock, valued at approximately $6,483,390.13. This represents a 4.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 10.50% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Consumer Staples Stocks, Explained
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- Health Care Stocks Explained: Why You Might Want to Invest
- MarketBeat Week in Review – 11/18 – 11/22
- Are Penny Stocks a Good Fit for Your Portfolio?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.